药品名称DARVON
申请号010997产品号003
活性成分PROPOXYPHENE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格65MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构XANODYNE PHARMACEUTICS INC
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
010997052APLabel2009/10/01下载
010997052APMedication Guide2009/10/01下载
010997052APOther2009/10/01下载
010997052APLetter2009/10/26下载
010997051APLetter2009/11/13下载
010997051APMedication Guide2009/10/01下载
010997051APLabel2009/09/30下载
010997043APLetter2002/08/01下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
010997052AP2009/09/25Labeling Revision
010997051AP2009/09/25Labeling Revision
010997047AP1999/02/24Manufacturing Change or Addition
010997046AP1998/10/05Manufacturing Change or Addition
010997045AP1998/08/10Control Supplement
010997044AP1998/04/02Package Change
010997043AP2002/08/01Labeling Revision
010997042AP1994/09/02Labeling Revision
010997041AP1992/09/15Control Supplement
010997040AP1994/08/23Labeling Revision
010997035AP1986/12/08Control Supplement
010997033AP1986/10/16Labeling Revision
010997032AP1986/11/05Control Supplement
010997031AP1986/04/21Labeling Revision
010997028AP1986/04/21Labeling Revision
010997027AP1986/04/21Labeling Revision
010997026AP1985/01/28Control Supplement
010997025AP1981/10/28Labeling Revision
010997024AP1981/05/20Labeling Revision
010997023AP1981/08/10Formulation Revision
010997022AP1980/04/15Labeling Revision
010997021AP1979/09/26Labeling Revision
010997020AP1978/10/13Package Change
010997019AP1978/05/26Formulation Revision
010997018AP1979/02/27Expiration Date Change
010997016AP1980/01/21Control Supplement
010997015AP1977/05/03Package Change
010997014AP1977/05/03Package Change
010997013AP1976/07/23Labeling Revision
010997010AP1975/01/06Labeling Revision
010997000AP1957/08/16Approval